Speakers
Mary K. Sendi, PharmD
MI Regional Lead North America, Pfizer Inc, United States
Mary is the Regional North America Lead for Pfizer Medical Information [MI]. Mary earned both a Bachelors and Doctorate degree in Pharmacy. Mary has greater than 20 years pharmaceutical industry experience specific to medical information. Outside of Pfizer, Mary is active in advancing the medical information profession through her leadership/collaboration roles in the Drug Information Association and phactMI [Pharma Collaboration for Transparent Medical Information]. Mary is currently serving on the phactMI board of directors for the term 2019-2020.
D. Stuart Sowder, JD, PharmD, MBA
Vice President, Compliance Lead, Asia, Pacific, Africa, Middle East, Pfizer Holdings, United States
Stuart Sowder, Vice President at Pfizer is currently responsible for compliance oversight for Asia, Pacific, African, and the Middle East. He is based in Tokyo. Previously, he led Pfizer’s External Medical Communications (EMC). Stuart received a B.S. degree in Pharmacy, his Doctorate of Pharmacy, and a JD at New York Law School. He earned a MBA from Duke University’s Fuqua School of Business. Stuart joined Pfizer in 1997 after a career in hospital pharmacy at the Veteran’s Administration in Manhattan. Since joining Pfizer, he has held positions of increasing responsibility starting in the field force, moving on to Pfizer Outcomes Research, the Regional Medical Research Specialists, External Medical Communications, and now Compliance.
Jeffrey K. Francer, JD
Vice President, Head of Global Regulatory Policy and Strategy, Eli Lilly and Company, United States
Jeff Francer is Assistant General Counsel of the Pharmaceutical Research and Manufacturers of America (PhRMA), where he provides advice and advocacy to the Association and its member companies on FDA regulatory and policy matters.
Kristin Graham Koehler, JD
Partner, Sidley Austin LLP, United States
Kristin Graham Koehler is a partner in the Washington, DC Office of Sidley Austin LLP and has significant experience in developing corporate compliance and audit programs in the life sciences industry. And, she has negotiated numerous Corporate Integrity Agreements with the HHS OIG.
Have an account?